1. Germany Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
RHON-KLINIKUM AG Unsponsored ADR

RHON-KLINIKUM AG Unsponsored ADR

RKAGY
RHON-KLINIKUM AG Unsponsored ADRUS flagOther OTC
8.16
USD
- -
- -
1.09BMarket Cap

Total Valuation

RHON-KLINIKUM AG Unsponsored ADR carries a market capitalization of 1.09B, placing it among publicly traded companies globally. Its enterprise value stands at 420.88M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.09B
Enterprise Value420.88M

Share Statistics

RHON-KLINIKUM AG Unsponsored ADR currently has 66.94M shares outstanding.

Shares Outstanding66.94M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

RHON-KLINIKUM AG Unsponsored ADR trades at a trailing price-to-earnings ratio of 24.16. The price-to-sales ratio is 0.56, and the price-to-book ratio stands at 5.78.

PE Ratio24.16
PS Ratio0.56
PB Ratio5.78
P/TBV Ratio0.81
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, RHON-KLINIKUM AG Unsponsored ADR trades at an EV/EBITDA multiple of 11.27 and an EV/FCF ratio of 170.00. The EV/Sales ratio of 0.24 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.27 provides insight into valuation relative to core operating earnings.

EV / Sales0.24
EV / EBITDA11.27
EV / EBIT11.27
EV / FCF170.00

Financial Position

RHON-KLINIKUM AG Unsponsored ADR maintains a current ratio of 2.57, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

Current Ratio2.57
Quick Ratio1.63
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage12.20

Financial Efficiency

RHON-KLINIKUM AG Unsponsored ADR posts a return on equity of 23.93 and a return on invested capital of 2.22.

Return on Equity (ROE)23.93
Return on Assets (ROA)2.16
Return on Invested Capital (ROIC)2.22
Return on Capital Employed (ROCE)20.43
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover32.24

Taxes

Over the trailing twelve months, RHON-KLINIKUM AG Unsponsored ADR has paid 9.95M in income taxes, reflecting an effective tax rate of 19.12.

Income Tax9.95M
Effective Tax Rate19.12

Stock Price Statistics

RHON-KLINIKUM AG Unsponsored ADR's stock has gained approximately 10.71913% over the past 52 weeks. The 50-day moving average sits at 8.16, while the 200-day moving average is 7.86.

Beta (5Y)N/A
52-Week Price Change10.71913%
50-Day Moving Average8.16
200-Day Moving Average7.86
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, RHON-KLINIKUM AG Unsponsored ADR generated 1.73B in revenue and converted that into 40.05M in net income, yielding earnings per share of 0.31. EBITDA reached 37.33M, while operating income came in at 37.33M.

Revenue1.73B
Gross Profit487.15M
Operating Income37.33M
Pretax Income52.03M
Net Income40.05M
EBITDA37.33M
EBIT37.33M
Earnings Per Share (EPS)0.31

Balance Sheet

Total book value stands at 167.41M, with working capital of 559.57M providing operational flexibility.

Cash & Cash Equivalents578.26M
Total DebtN/A
Net Debt-160.44M
Equity (Book Value)167.41M
Book Value Per Share1.22
Working Capital559.57M

Margins

RHON-KLINIKUM AG Unsponsored ADR operates with a gross margin of 28.22, reflecting its pricing power and cost economics. The operating margin of 2.16 and net profit margin of 2.32 provide insight into operational efficiency.

Gross Margin28.22
Operating Margin2.16
Pretax Margin3.01
Profit Margin2.32
EBITDA Margin2.16

Scores

RHON-KLINIKUM AG Unsponsored ADR posts an Altman Z-Score of 2.73, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.73